Fab’entech, specialized in specific polyclonal immunoglobulins against emerging infectious diseases, raised € 5 million from Auriga Partners, Rhône-Alpes Création, Sigma Gestion and historic shareholders . This investment will allow Fab’entech to expand internationally.
Attorney for the investors: Pinot de Villechenon & Associés (Morgan Hunault-Berret, Alexander Kotopoulis)
Attorney for the company: Jakubowicz Mallet-Guy & Associés (Loïc Jeambrun)
La Lettre Capital Finance, June 24, 2014